July 19, 2008Critics question FDA, U.S. Customs handling of Ranbaxy case - Newark Star-Ledger Critics question FDA, U.S. Customs handling of Ranbaxy case - Newark Star-Ledger
For two and a half years, the Food and Drug Administration collected evidence that Ranbaxy Laboratories, India's largest generic drugmaker, may have lied about the quality of medicines and chemicals it sent to the U.S. Regulators inspected Ranbaxy Source: www.nj.com # posted by Network @ 1:00 PM
 |
Subscribe to Posts [Atom]